Results for: Subcutaneous Injection
Find the latest Subcutaneous Injection tenders from different organizations. SigmaTenders helps you participate in these online e-Procurement tenders. We provide access to tender details, BOQs, and technical bids, along with bidding support for Subcutaneous Injection e-tenders. Stay informed with daily email alerts and comprehensive coverage across government websites, GeM, and e-Procurement portals.
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
π Urgent Tender for Diabetes Care Insulins π The Ministry of Railways, under the Central Government, invites tenders for the supply of specialized diabetes care insulins. The tender includes the following products: 1. Soluble Insulin (30%) and Isophane Insulin (70%) - 10 ML Vial with 40 IU/ML 2. Insulin Aspart (30%) and Protamine Insulin Aspart (70%) Suspension - 3 ML Cartridge 3. Monocomponent Biosynthetic R-DNA Insulin Solution for Injection in 3 ML Cartridge for Subcutaneous Use (70% Insulin Degludec/30% Insulin Aspart) - Prefilled Penfill 100 Units/ML ποΈ Deadline: May 27, 2024, 2:30 PM Interested bidders should submit detailed tenders, including all mandatory documents, as per the tender specifications. No tender fee or earnest money deposit (EMD) is required. Keywords: Insulin, Diabetes Care, Tender, Ministry of Railways, Central Government, Procurement, Medical Supplies, Biosynthetic Insulin, Prefilled Penfill, Tender Submission
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
π Procurement Opportunity: Human Growth Hormone Injection π The Ministry of Railways, specifically the Central Govt. Ministry/Department, is seeking a supplier for Human Growth Hormone Injections with specific requirements. π π Specifications: - Contains Somatotropin, Recombinant DNA origin. - Prefilled, Pre-Loaded, Flex Pro Pen with no external reconstitution needed. - Comes with a minimum of 15 IU/ml of 36G Disposable needles for subcutaneous use. π Additional Requirements: - Growth charts for patient follow-up. - Product demonstration and ease of administration. π Bid Submission Deadline: May 24, 2024, 11:00 AM Interested suppliers must provide a detailed bid, including product demonstration and compliance with the above specifications, by the deadline. Keywords: Human Growth Hormone Injection, Somatotropin, Recombinant DNA, Flex Pro Pen, Disposable Needles, Growth Charts, Ministry of Railways, Procurement, Tender
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensu
For complete deion and other details, please refer to tender
π Procurement Opportunity: Human Growth Hormone Injection π The Ministry of Railways, specifically the Central Govt. Ministry/Department, is seeking a supplier for Human Growth Hormone Injection with specific requirements: 1. The HGH should contain Somatotropin, of recombinant DNA origin. 2. The product must be prefilled, pre-loaded, and easy to use with a Flex Pro Pen, requiring no external reconstitution. 3. Each pen should come with a minimum of 15 IU (International Units) of 36G Disposable needles for subcutaneous use. 4. Suppliers must provide growth charts for patient follow-up during therapy. 5. A demonstration of the product and its ease of administration is mandatory. ποΈ Deadline for submission: April 29, 2024, 10:30 AM Interested suppliers are requested to submit detailed bids, including all necessary documentation and compliance with the tender specifications, by the stipulated deadline. Keywords: Human Growth Hormone Injection, Somatotropin, Recombinant DNA, Flex Pro Pen, Disposable Needles, Growth Charts, Ministry of Railways, Central Govt. Ministry/Department, Tender, Procurement
Need support responding to this opportunity?
Get matched through GetSaarthi for documentation, proposal preparation, compliance readiness, and execution support.
Get Opportunity Matching Supportof your Industry type